Phericsin Tablet (Clonixin Lysinate)

Adult dose

○ Adults: Administer 125∼250 mg per dose orally 3 times daily as clonixin lysinate.

This medication may cause gastrointestinal bleeding in individuals who regularly consume more than three drinks per day, so it is necessary to consult a physician or pharmacist. This medication may affect the cardiovascular system, so patients with cardiovascular diseases or risk factors should be particularly cautious, and if cardiovascular symptoms occur, they should consult a healthcare professional immediately. This medication may increase the risk of gastrointestinal bleeding, ulcers, perforations, etc., so elderly patients or those with a history of gastrointestinal issues should be especially careful, and if any abnormal symptoms occur, immediate evaluation and treatment are necessary. Patients with peptic ulcer disease, hypersensitivity to this medication or its components, a history of asthma or allergic reactions, pregnant women, and patients with severe liver, kidney, or heart diseases should not take this medication. It is necessary to be cautious of interactions and adverse effects when combined with other non-steroidal anti-inflammatory drugs, ACE inhibitors, aspirin, diuretics, lithium, methotrexate, anticoagulants, etc., so avoid using them together or proceed with caution. Individuals with a history of peptic ulcers, elderly age, hypertension, heart failure, or liver and kidney disorders must consult a healthcare professional before taking this medication. It is advisable to avoid breastfeeding while taking this medication, and if any abnormal symptoms (nausea, vomiting, abdominal pain, skin rash, anemia, liver function abnormalities, etc.) occur, discontinue use immediately and consult a healthcare professional. This medication should be taken for the shortest duration and at the minimum effective dose, and regular monitoring for adverse reactions is necessary during long-term use. Moreover, this medication may mask inflammatory symptoms and delay the diagnosis of infectious complications, so it should be used carefully along with appropriate antibiotics if an infection is suspected. This medication should be kept out of reach of children and not transferred to other containers.

Gastrointestinal bleeding, severe cardiovascular thrombotic reactions, myocardial infarction, stroke, bleeding of the stomach or intestines, ulcers, perforation, nausea, vomiting, diarrhea, constipation, abdominal pain, shock, rash, itching, anemia, increased AST, increased ALT, drowsiness, headache, dizziness, sweating, chills, abnormal euphoria, jaundice, fulminant hepatitis, liver necrosis, liver failure, anemia, fluid retention, edema, renal failure, anaphylactic-like reactions, exfoliative dermatitis, mucocutaneous syndrome, toxic epidermal necrolysis, bronchospasm, temporary infertility

Drug interactions

Do not take this medication along with other non-steroidal anti-inflammatory drugs, ACE inhibitors or angiotensin II receptor antagonists, aspirin, diuretics, lithium, methotrexate, coumarin anticoagulants (such as warfarin), cyclosporine and tacrolimus, antiplatelet agents, and selective serotonin reuptake inhibitors (SSRIs), and corticosteroids. If you are taking misoprostol, a peptic ulcer treatment, please consult your physician.

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. The recommended storage temperature is between 1 and 30 degrees Celsius at room temperature. This will help maintain the effectiveness of the medication for a longer period while ensuring its safe use.

Appearance

Yellowish round film-coated tablet

Package unit

10 tablets (10 tablets/PTP x 1)